Trade Gilead GILD

Gilead live chart

Instrument Fundamentals

Weekly Search
Weekly
Daily
Date Close Change Change (%) Open High Low

Gilead News

Julian Parker 2026 Nov 01, 16:03

UAE Fuel Price Prediction: November 2026 Rates Fall—What Comes Next?

Julian Parker 2026 Oct 29, 16:03

AED to PKR Forecast: What Could Move the Dirham–Rupee Rate?

Julian Parker 2026 Oct 28, 16:03

AED to EGP Forecast: Will the Dirham Buy More Egyptian Pounds?

silver price prediction aed
Daniel Carter 2026 Oct 27, 16:03

Silver Price Prediction 2026–2030: What Could Silver Cost in the UAE?

Oil Price Forecast 2026
Daniel Carter 2026 Oct 27, 16:03

Oil Price Forecast 2026–2030: What UAE Traders Should Watch

cfd-trade
Julian Parker 2026 Oct 20, 16:03

Best Stocks to Buy in UAE: 7 Companies to Watch and Compare

gold price trend 2024 to 2026 analysis facts
2026 Aug 24, 16:03

Gold Price Trend 2024-2026: From $2,000 to Record Highs, What Comes Next?

Best Broker in the UAE With a Welcome Bonus
2026 Aug 12, 16:03

Best CFD Brokers in the UAE with Welcome Bonuses in 2026

markets.com
2026 Jul 16, 16:03

Markets.com Review 2026: Is It the Best CFD Trading Platform?

Latest news

Show more
Julian Parker 2026 Nov 02, 16:03

J.P. Morgan Opens DIFC Private Banking Branch, Expanding Dubai Wealth Business

gold rate in UAE today
Daniel Carter 2026 Nov 02, 16:03

Gold Rate in UAE Today Holds at AED 478 as XAU/USD Rebounds Above $3,900

oil price news today uae
Daniel Carter 2026 Nov 02, 16:03

Oil Price Today UAE: Brent Crashes Below $105 as Iran Peace Hopes Return

Bitcoin price in UAE
Daniel Carter 2026 Nov 02, 16:02

Bitcoin Price in UAE Falls Toward AED 282,000 as Binance Withdrawals Reach $3.6 Billion

Julian Parker 2026 Nov 01, 16:03

UAE Fuel Prices Fall in November as Petrol Drops 24 Fils per Litre

gold rate in UAE today
Daniel Carter 2026 Nov 01, 16:02

Gold Rate in UAE Today Rises to AED 470.50 as XAU/USD Rebounds Above $3,900

Julian Parker 2026 Oct 29, 16:05

FAB Nine-Month Net Profit Rises to AED16.46 Billion as Lending Expands

Julian Parker 2026 Oct 29, 16:04

Dubai Stocks Fall 0.47% as Investors Assess Earnings and Steady UAE Rates

Info

Spread

1.04

Spread (%)

0.6229 %

Leverage

1:10

Overnight Interest Buy

-0.0597 %

Overnight Interest Sell

-0.0292 %

Currency

USD

Trading Hours

Markets closed

Wednesday

14:31 - 20:59

Monday

14:31-20:59

Tuesday

14:31-20:59

Thursday

14:31-20:59

Friday

14:31-20:59

Analysis and statistics

Open

---

Previous Close

---

52 Week High/Low

--- – ---

Market cap

211266863104

Shares Outstanding

1240338614

Earnings Date (Next)

2013-01-28

Div Yield

2026-12-30

Ex-Dividend Date

2026-12-15

Forward annual dividend rate

3.28

Forward annual dividend yield

0.0193

EPS

-3.13

Learn more about this instrument

Gilead Gilead Sciences Inc
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Descovy, Genvoya, Odefsey, Sunlenca, Symtuza, and YeztugoFor the treatment of HIV-1 infection in patients. It also provides Epclusa, Livdelzi, and Vemlidy to treat chronic hepatitis C virus, primary biliary cholangitis, and chronic hepatitis B virus; Tecartus, a T-cell therapy for the treatment of adult patients; Trodelvy, an injection for intravenous use; and Yescarta, a suspension for intravenous infusion, is a CAR T-cell therapy for the treatment of adult patients. Further, it provides AmBisome, for the treatment of serious invasive fungal infections; and Veklury for the treatment of COVID-19. Additionally, the company engages in the development of various immunotherapies for patients with cancer and other incurable diseases. The company has collaboration agreements with Shenzhen Pregene Biopharma Co., Ltd.; Abingworth; Arcus Biosciences, Inc.; Merck Sharp & Dohme Corp.; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, Inc.; Everest Medicines; Merck & Co, Inc.; Tentarix Biotherapeutics Inc.; and Assembly Biosciences, Inc. It also has research collaboration, option, and license agreement with Merus N.V. for the discovery of novel dual tumor-associated antigens (TAA) targeting trispecific antibodies. The company has a collaboration with Terray Therapeutics, Inc. to discover and develop small molecule therapies; and LEO Pharma to develop, manufacture, and commercialize the small molecule oral STAT6 program. The company has a partnership with Pan American Health Organization (PAHO) to accelerate access to lenacapavir for HIV prevention as pre-exposure prophylaxis (PrEP) across all PAHO member states in Latin America and the Caribbean. The company was incorporated in 1987 and is headquartered in Foster City, California.

Related Instruments

Asset
Sell
Buy
Change (%)
View all instruments

Latest Education Articles

Show more
Julian Parker 2026 Nov 02, 16:04

Best Place to Buy Gold in the UAE: Where to Buy Bars, Coins and Jewellery

Gold pice impact on dubai
Julian Parker 2026 Nov 02, 16:03

How Does the Iran War Affect Gold Prices in Dubai?

us midterm elections 2026
Daniel Carter 2026 Nov 02, 16:02

US Midterm Elections 2026: How Could the Results Affect UAE Investors?

Trustpilot